teva pharmaceutical-sp adr
Robert Koremans M.D.
Chief Executive Officer of Global Specialty Medicines Group and President of Global Specialty Medicines Group, Teva Pharmaceutical Industries Limited
|Age||Total Calculated Compensation||This person is connected to 5 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Mr. Robert Koremans, also known as Rob, M.D. has been Chief Executive Officer and President of Global Specialty Medicines Group at Teva Pharmaceutical Industries Limited since April 24, 2013. Mr. Koremans served as the Chief Executive Officer and President of Teva Europe at Teva Pharmaceutical Industries Limited since March 2012. He served as the Chairman and the Chief Executive Officer of Zentiva N.V. from July 1, 2010 to 2011 and its President from September 01, 2009 ...
5 Basel StreetPhone: 972 3 926 7267
Petach Tikva, -- 49131
Fax: 972 3 923 4050
Board Members Memberships*
Former Chief Executive Officer, Managing Director and director
Chairman, Chief Executive Officer and President
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|José E. Almeida||Chairman, Chief Executive Officer and President|
|$1.2M||Compensation as of Fiscal Year --.|